In the present study, the serum levels of IL-33, IL-17 and IL-25 were determined in patients with chronic hepatitis C (CHC) and hepatocellular carcinoma (HCC) and compared to healthy controls (C). Here, IL17A is linked to hepatocellular carcinoma.